Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.28027 | 51 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.27019 | 52 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.2396 | 51 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.15052 | 50 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.18917 | 51 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.3296 | 51 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.4711 | 55 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.21926 | 51 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.17836 | 50 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.19556 | 51 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.24077 | 52 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.22185 | 52 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.2421 | 51 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.25739 | 52 |